Polymorphism in IL1B: IL1B-511 association with tuberculosis and decreased lipopolysaccharide-induced IL-1β in IFN-γ primed ex-vivo whole blood assay

Journal of Endotoxin Research

Volumn 11, Issue 5, 2005, Pages 281-286

  Awomoyi, Agnes A ^a,b   Charurat, Manhattan ^c   Merchant, Arnaud ^a   Miller, E Nancy ^d   Blackwell, Jenefer M ^d   McAdam, Keith P W J ^a   Newport, Melanie J ^a,e  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c INSTITUTE OF HUMAN VIROLOGY   (United States)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

Author keywords

Ex vivo whole blood assay; IL1B polymorphism; Interleukin 1 ; Tuberculosis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NUCLEOTIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOASSAY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ETHNOLOGY; EX VIVO STUDY; GAMBIA; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; PROTEIN FAMILY; RISK FACTOR; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; FEMALE; GAMBIA; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN-1; TUBERCULOSIS, PULMONARY;

EID: 27644438874     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805105X58706     Document Type: Article

References (27)

1. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 6: 2095-2147.
2. Dinarello CA. The role of the interleukin 1 receptor antagonist in blocking inflammation mediated by interleukin 1. N Engl J Med 2000; 343: 732-734.
3. Sica A, Wang JM, Colotta F et al. Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J Immunol 1990;144: 3034-3038.
4. Hunter CA, Chizzonite R, Remington JS. IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens. J Immunol 1995; 155: 4347-4354.
5. Tsao TCY, Hong J, Li LF, Hsieh MJ, Liao SK, Chang KSS. Imbalances between tumor necrosis factor-α and its soluble receptor forms, and interleukin-1β and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis. Chest 2000; 117: 103-109
6. Juffermans NP, Florquin S, Camoglio L et al. Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J Infect Dis 2000; 182: 902-908.
7. Nicklin MJ, Barton JL, Nguyen M, FitzGerald MG, Duff GW, Komman K. A sequence-based map of the nine genes of the human interleukin-1 cluster. Genomes 2002; 79: 718-725.
8. Clark BD, Collin KL, Gardy MS, Webb AC, Auron PE. Genomic sequence for human prointerleukin 1 beta: possible evolution from a reverse transcribed prointerleukin 1 alpha gene. Nucleic Acids Res 1986; 14: 7897-7914.
9. El-Omar ME, Carrington M, Chow W-H et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2001; 412: 99.
10. Pociot F, Molvig J, Wogensen L, Worsaae H, Nemp JA, Taq 1 polymorphisms in the human interleukin 1 β (IL-1beta) gene correlates with IL-1β secretion in vitro. Eur J Clin Invest 1992; 22: 396-402.
11. Tarlow JK, Blakemore AIF, Lennard A et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable number of an 86 bp tandem repeat. Hum Genet 1993; 91: 403-404.
12. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL1RA) gene polymorphism. Clin Exp Immunol 1995; 99: 303-310
13. Wilkinson RJ, Patel P, Llewelyn M et al. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1β on tuberculosis. J Exp Med 1999; 189: 1863-1873.
14. Awomoyi AA, Marchant A, Howson JM, McAdam KP, Blackwell JM, Newport MJ. Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. J Infect Dis 2002; 186: 1808-1814
15. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, vol. 2. Cold Spring Harbour: Cold Spring Harbour Laboratory Press, 1989.
16. Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ 1995; 310: 170.
17. Blakemore AIF, Watson PF, Weetman AP, Duff GW. Association of Graves' disease with an allele of the interleukin 1 receptor antagonist gene. J Clin Endocrinol Metab 1995; 80: 111-115.
18. Blakemore AIF, Tarlow J, Cork MJ, Gordon C, Emery P, Duff GW. Interleukin 1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 1994; 37: 1380-1385.
19. Mansfield JC, Holden H, Tarlow JK et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 60: 637-642.
20. Clay FE, Cork MJ, Tarlow JK et al. Interleukin-1 receptor antagonist gene polymorphism association with lichen sclerosus. Hum Genet 1994; 94: 407-410.
21. Crusius JBA, Pena AS, van Oosten BW et al. Interleukin 1 receptor antagonist gene polymorphism and multiple sclerosis. Lancet 1995; 346: 979-980
22. Hamajima N. Interleukin 1 polymorphism, lifestyle factors and Helicobacter pylori infection. Jpn J Cancer Res 2001; 92: 383-389.
23. Read RC, Camp NJ, di Giovine FS et al. An interleukin-1 genotype is associated with fatal outcome of meningococcal disease. J Infect Dis 2000; 182: 1557-1560.
24. Bellamy R, Ruwende C, Corrah T, McAdam KPWJ, Whittle HC, Hill AVS. Assessment of the interleukn-1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tubercle Lung Dis 1998; 79: 83-89.
25. Newport MJ, Allen A, Awomoyi AA et al. Toll-like receptor 4 Asp299Gly: no association with tuberculosis and allele frequency distribution in The Gambia. Tuberculosis 2004; 84: 347-352.
26. Yang Z, Wara-aswapati N, Chen C, Tsukada J Auron PE. NF-IL6 (C/ERPb) vigorously activates IL-1β gene expression via Spi-1 (PU.1) protein-protein tether. J Biol Chem 2000; 275: 21272-21277.
27. Tsukada J, Toda Y, Misago M, Tanaka Y, Auron PE, Eto S. Constitutive activation of LIL-Stat in adult T cell leukemia cells. Blood 2000; 95: 2715-2718.